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Abstract—Pharmacovigilance is a method of quick detection and 
reporting, of adverse drug reactions and adverse drug events 
after drug is in clinical use, thus preventing major drug events. 
Ignorance of physicians in developing world, about reporting 
adverse drug reaction is a big roadblock to pharmacovigilance. 
This cascades into many problems e.g.; increased lab to clinic 
interval, increased premarketing expense for newer drugs. In 
quickly changing genomes scenario it leads to almost fatal 
therapeutic failures. The huge population of India and lack of 
appropriate post marketing surveillance contribute towards 
disasters due to adverse drug reactions.  With evolution of 
pharmaceutical industry, the Indian doctors have gained wide 
knowledge of drugs but the area of adverse drug reactions still 
remains neglected. Indian Government launched National 
Pharmacovigilance Programme in 2004 to inculcate the culture 
of Adverse Drug Reaction reporting among Indian health 
professionals. Medical Council of India has also made 
Pharmacovigilance Programme mandatory in every medical 
college. Still the picture is disheartening. Motivated to improve 
Adverse Drug Event reporting in Chattrapati Shivaji Subharti 
Hospital, the present survey was conducted to find Knowledge, 
Attitude, Practices (KAP) of physicians, surgeons & nurses 
regarding Adverse Drug Reaction reporting. 
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Adverse drug reactions are a major cause of morbidity and 
mortality. Pharmacovigilance is a method of quick detection, 
of adverse drug reactions and adverse drug events after drug 
is in clinical use, thus preventing major drug events. 
The true essence of Pharmacovigilance would be achieved 
only when physicians, nurses and other health professionals 
inculcate the habit of voluntary adverse drug reaction 
reporting. 
India is emerging as a major hub of pharmaceutical 
industry. The Indian pharmaceutical market has flourished 
with the introduction of new drugs with the help of clinical 
research. But, in the realm of this tremendous boom of 
pharmaceuticals, the hazards due to adverse drug reactions 
appear to have been ignored. Indian companies are among the 
world leaders in the production of generics and vaccines – 
now producing more than 20% of the world’s generics. Since 
Indian firms will be marketing products globally they will 
have to fulfill the regulatory requirements of respective 
countries as well, post marketing surveillance of new drugs 
being one. But unfortunately ADR reporting is very low in 
India. This ugly situation can be improved by implementing 
adequate laws such as insurance against adverse drug 
reactions for general public, inclusion of pharmacovigilance 
under corporate social responsibility, encouraging regulatory 
authorities to take educative and publicizing role and by 
identifying each and every component of a drug including the 
excipients and preservatives while assessing the root cause of 
particular adverse drug event. 
 
II. PHARMACOVIGILANCE IN INDIA 
 
The National Pharmacovigilance Programme of India is 
largely based on the recommendations made in the WHO 
document titled “Safety Monitoring of Medicinal Products-
Guidelines for Setting Up and Running a Pharmacovigilance 
Centre”. The Programme aims to foster the culture of 
Adverse Drug Event notification and aims to generate broad 
based adverse drug reaction database on the Indian 
population and share the information with others, and to 
ensure optimum safety of drug products in the Indian market. 
Despite the efforts of Drug Controller General Of India 
(DCGI) and Indian Council of Medical Research (ICMR) in 
establishing adverse drug reaction monitoring centres in 
many hospitals in the major cities of India and the presence 
of a large number of tertiary care facilities , 
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pharmacovigilance is still in its infancy in India. Gross under 
reporting of adverse drug reactions is a cause of concern, the 
reasons for which may be many. Realizing the importance of 
the task, Medical Council of India has made it mandatory for 
all medical colleges to have an adverse drug reaction training, 
monitoring and reporting program. There is still a lack of 
understanding on this topic like how it functions, what are the 
benefits of sharing Adverse Drug Reaction knowledge and its 
purpose and importance. To fulfill the above aim it is 
important to find out the perception of doctors about adverse 
drug reaction reporting and identify steps which will improve 
adverse drug reaction reporting and fulfill the goals of 
Medical Council Of India. Keeping these facts in mind, this 
study was conducted to assess awareness of 
pharmacovigilance among physicians and nurses in an Indian 
peripheral care teaching hospital. 
. 
III. ROLE OF TRAINING PROGRAMME IN 
ADVERSE DRUG REACTION REPORTING 
 
Many studies show that active interventions, training 
programme, sensitization and continuous follow up, 
significantly increase number of spontaneous adverse drug 
reaction reporting. 
 A study conducted in Portugal included in its training 
program a workshop with sessions giving a brief introduction 
about the problem of Adverse Drug Reactions and its impact 
on public health, This was followed by an approach to 
spontaneous reporting of Adverse Drug Reactions. It also 
conducted telephonic interviews. Educational interventions 
conducted in workshops or telephone interviews significantly 
increased the number and relevance of spontaneous Adverse 
Drug Reactions reports by pharmacists of Northern Portugal.1 
A study conducted in Manipal, India also included an 
educational intervention that was divided into a theoretical 
and a practical part. The theoretical part consisted of a 
presentation on how to report a suspected adverse drug 
reaction, economic and epidemiological importance of 
reporting the Adverse Drug Reactions and its effect on patient 
safety,  the definition of pharmacovigilance, classification of 
ADRs (various tools for assessing ADRs in terms  of 
causality, preventability, severity, Adverse Drug Reactions 
reporting cards from various countries, ADR alert cards, 
WHO online database for reporting adverse drug reactions). 
This study also utilized Knowledge, Attitude, Practices 
questionnaire to assess the knowledge of health care 
professionals. The result of this study showed increased 
awareness of pharmacovigilance among health care 
professionals.2 
Mala Kharkhar, et al conducted a study in Mumbai on 
Knowledge, Attitude and Perception of doctors on Adverse 
Drug Reaction monitoring by designing a right questionnaire 
based study. The study revealed that practitioners were aware 
of Adverse Drug Reactions reporting. Their perception toward 
Adverse Drug Reactions reporting was right but it did not 
reflect in their attitude when it came  to the act of reporting of 
Adverse Drug Reactions.3 
Mrin Moy Chakrabarty,et.al in their study found that 
ensuring proper education and frequent updating of health 
care professionals by training them in data collection, 
filtration,  verification, interpretation and coding of Adverse 
Drug Reactions, medicines coding, causality assessment, 
signal detection, risk management, and action in case of 
serious/fatal adverse drug events (ADE) had improved 
reporting of Adverse Drug Reactions.4 
Chetna K. Desai and co-workers in her study used a 
pretested Knowledge, Attitude, Practices questionnaire 
comprising of 15 questions. The study showed that physicians 
were aware of the Adverse Drug Reactions and the importance 
of their reporting. However, under reporting and lack of 
knowledge about the reporting system were clearly evident.5 
        Roald Gerritsen and co workers compared the 
lecture-based pharmacovigilance training methods with the 
practice based method by analyzing the number and quality of 
reports sent in by graduate general practitioners who had been 
offered one of both approaches during their vocational 
training. The practice based methods resulted in significantly 
more and better documented reports and more often 
concerned unlabelled events than the lecture-based method.6 
Peter Mansellet. al opined that pharmacovigilance had 
tended to be a backroom function in the pharmaceutical 
industry, and a largely reactive one too. Patient safety and 
public health should sit at the heart of corporate social 
responsibility.7 
 Patrick K.J Crowley and co-workers discovered that 
Drugs may interact directly with excipients or with residues 
or impurities therein. Such interactions may be modest, slow 
and take time to be detected in conventional stability studies. 
This can complicate and even delay project progression. 
When designing dosage forms therefore it is important to be 
aware of the potential for excipients to adversely affect quality 
and may lead to ADRs.8 
 
IV. OUR OWN EXPERIENCE AT SUBHARTI 
 
a) Adverse Drug Reaction reporting is very poor in our 
500 bedded, well equipped and fully staffed Chattrapati 
Shivaji Subharti Hospital,  Meerut,  Meerut is an important 
medical care centre of western U.P, located about 70 km from 
national capital, New Delhi. It boasts of about 250 practising 
doctors of various specialities, super specialities, with large 
number of hospitals and nursing homes. Sadly, spontaneous 
adverse drug reaction reporting is negligible despite 
continuous effort of our department which is a peripheral 
centre under National Pharmacovigilance Programme 
launched by Government of India in 2004. Worried by poor 
reporting of adverse drug events from our hospital, I was 
given thesis dissertation topic on Pharmacovigilance. The 
present study, a pilot study was conducted on 100 health 
care professionals of Chattrapati Shivaji Subharti 
Hospital (CSSH) Meerut to ascertain their Knowledge, 
Attitude, Practices (KAP) with the help of a questionnaire. 
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V. OBSERVATIONS & RESULTS 
 
All the data were tabulated and analyzed and the results were 
expressed in percentages. Based on the response received 
from the concerned Healthcare professionals, the following 
conclusions were derived: 
The reasons for underreporting of ADRs were: 
 Non-availability of forms (97%) 
  Absence of stringent laws pertaining to adverse 
drug events reporting  (89%) 
 Lack of awareness of Adverse Drug Reaction 
reporting form of Central Drug Safety Control 
Organisation (CDSCO) 68% 
 Non-communication about Adverse Drug Reactions 
of a new product by medical representatives (78%) 
 Lack of training as well as paucity of time (73%) 
(Table 1) 
 
Suggested measures to increase reporting were: 
 Continuous Medical education (96%) 
 Compulsory reporting of adverse drug reactions 
(89%) 
 Information to consumer (80%) 
 Postal /online service for filling forms (76%) (Table 
2) 
TABLE I.  REASONS FOR UNDERREPORTING OF ADVERSE 
DRUG REACTIONS 
Reasons for underreporting %(n=100) 
Lack of training as well as paucity of 
time 
7     73% 
Non-availability of forms 
 
97% 
Lack of law 89% 
Lack of awareness of Adverse Drug 
Reaction reporting form of Central 
Drug Safety Control Organization 
(CDSCO) 
68% 
Non-communication about Adverse 
Drug Reactions of a new product by 
medical representatives  
78% 




TABLE 2. Suggested measures to increase   reporting 
 
Suggested measures to 





Compulsory reporting of 
adverse drug reactions 
89% 
Information to consumer 80% 







Based on the study, the following measures have been 
undertaken to improve ADR reporting in Subharti Medical 
College: 
1) Designing of simple and easy to fill ADR 
reporting forms separately for outpatient 
departments (OPDs) and internal patient 
departments (IPDs) in order to collect vital 
information essential for filling standard 
CDSCO forms; 
2) Regular training sessions for interns, junior 
residents and nurses about filling up of ADR 
forms designed by  our department and CDSCO 
; 
3) Regular visits to various OPDs to sensitize and 
remind doctors about ADR reporting; 
4) Training of junior residents on various tools for 
assessing ADRs in terms of causality, severity 
and preventability; 
5) Based on the information received from various 
departments about suspected ADRs, CDSCO 
forms are filled up centrally and sent to zonal 
office of pharmacovigilance. 
The study is still ongoing by undertaking above mentioned 
measures and it is our belief that with these measures in place, 
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